Sepsis and pathophysiology of anthrax in a nonhuman primate model

89Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

Studies that define natural responses to bacterial sepsis assumed new relevance after the lethal bioterrorist attacks with Bacillus anthracis (anthrax), a spore-forming, toxigenic gram-positive bacillus. Considerable effort has focused on identifying adjunctive therapeutics and vaccines to prevent future deaths, but translation of promising compounds into the clinical setting necessitates an animal model that recapitulates responses observed in humans. Here we describe a nonhuman primate (Papio c. cynocephalus) model of B. anthracis infection using infusion of toxigenic B. anthracis Sterne 34F2 bacteria (5 × 105 to 6.5 × 109 CFU/kg). Similar to that seen in human patients, we observed changes in vascular permeability, disseminated intravascular coagulation, and systemic inflammation. The lung was a primary target organ with serosanguinous pleural effusions, intra-alveolar edema, and hemorrhagic lesions. This animal model reveals that a fatal outcome is dominated by the host septic response, thereby providing important insights into approaches for treatment and prevention of anthrax in humans. Copyright © American Society for Investigative Pathology.

Cite

CITATION STYLE

APA

Stearns-Kurosawa, D. J., Lupu, F., Taylor, F. B., Kinasewitz, G., & Kurosawa, S. (2006). Sepsis and pathophysiology of anthrax in a nonhuman primate model. American Journal of Pathology, 169(2), 433–444. https://doi.org/10.2353/ajpath.2006.051330

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free